Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Safety, Pharmacokinetic and Dose-Escalation Study of KD019 in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)

This study is currently recruiting participants. (see Contacts and Locations)
Verified June 2016 by Kadmon Corporation, LLC
Information provided by (Responsible Party):
Kadmon Corporation, LLC Identifier:
First received: March 9, 2012
Last updated: September 15, 2016
Last verified: June 2016
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: September 2019 (Final data collection date for primary outcome measure)